- Home
- BATL vs MDAI Comparison
BATL vs MDAI Comparison
Compare BATL & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- MDAI
- Stock Information
- Founded
- BATL 1987
- MDAI 2013
- Country
- BATL United States
- MDAI United States
- Employees
- BATL N/A
- MDAI N/A
- Industry
- BATL Oil & Gas Production
- MDAI Medical/Dental Instruments
- Sector
- BATL Energy
- MDAI Health Care
- Exchange
- BATL Nasdaq
- MDAI Nasdaq
- Market Cap
- BATL 28.8M
- MDAI 28.3M
- IPO Year
- BATL N/A
- MDAI N/A
- Fundamental
- Price
- BATL $1.94
- MDAI $1.96
- Analyst Decision
- BATL
- MDAI Strong Buy
- Analyst Count
- BATL 0
- MDAI 3
- Target Price
- BATL N/A
- MDAI $4.50
- AVG Volume (30 Days)
- BATL 264.4K
- MDAI 1.6M
- Earning Date
- BATL 11-12-2024
- MDAI 11-06-2024
- Dividend Yield
- BATL N/A
- MDAI N/A
- EPS Growth
- BATL N/A
- MDAI N/A
- EPS
- BATL N/A
- MDAI N/A
- Revenue
- BATL $191,482,000.00
- MDAI $27,264,000.00
- Revenue This Year
- BATL $2.21
- MDAI $61.78
- Revenue Next Year
- BATL N/A
- MDAI N/A
- P/E Ratio
- BATL N/A
- MDAI N/A
- Revenue Growth
- BATL N/A
- MDAI 44.52
- 52 Week Low
- BATL $1.31
- MDAI $0.82
- 52 Week High
- BATL $9.66
- MDAI $3.72
- Technical
- Relative Strength Index (RSI)
- BATL 38.92
- MDAI 44.95
- Support Level
- BATL $1.76
- MDAI $1.91
- Resistance Level
- BATL $2.32
- MDAI $2.24
- Average True Range (ATR)
- BATL 0.20
- MDAI 0.33
- MACD
- BATL 0.12
- MDAI -0.09
- Stochastic Oscillator
- BATL 45.71
- MDAI 3.73
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.